JIBCX
Price
$68.20
Change
-$0.36 (-0.53%)
Updated
Sep 5 closing price
Net Assets
5.88B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

JIBCX vs RGEBX

Header iconJIBCX vs RGEBX Comparison
Open Charts JIBCX vs RGEBXBanner chart's image
JHancock Blue Chip Growth 1
Price$68.20
Change-$0.36 (-0.53%)
VolumeN/A
Net Assets5.88B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
JIBCX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JIBCX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIBCX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. JIBCX (5.88B). JIBCX (0.00) and RGEBX (0.00) have matching dividends . JIBCX was incepted earlier than RGEBX: JIBCX (20 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than JIBCX (0.82). RGEBX is a more actively managed with annual turnover of: 25.00 vs. JIBCX (12.00). JIBCX has a lower initial minimum investment than RGEBX: JIBCX (0) vs RGEBX (250). JIBCX (18.49) and RGEBX (17.59) have marching annual gain over last year. RGEBX return over 5 years is better than : 38.71 vs. JIBCX (24.16).
JIBCXRGEBXJIBCX / RGEBX
Total Expense Ratio0.811.0974%
Annual Report Gross Expense Ratio0.821.0975%
Fund Existence20 years11 years-
Gain YTD12.76515.39883%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.88B332B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.4917.59105%
Returns for 3 years76.2357.61132%
Returns for 5 years24.1638.7162%
Returns for 10 years95.7691.44105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd